Immunomodulation by adriamycin.

Immunomodulation by adriamycin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Immunomodulation by adriamycin. Abstract Text:

Immunomodulation by adriamycin. Publishing Authors By Initials

For similar neoplasms: neoplasms, experimental research abstracts see: neoplasms: neoplasms, experimental research

PUBMED ID PMID:

MEDLINE DATE:

Immunomodulation by adriamycin. Journal Published:

PUBLICATION TYPE: Review

Journal: The science reports of the research institutes, To

VOLUME: 32

Page Numbers: 10-3

Journal Abbreviation:

ISSN: 0371-2761

DAY: 26

MONTH: Dec

YEAR: 1985

Immunomodulation by adriamycin. Information

Number of References: 45

LANGUAGE: eng

NlmUniqueID: 234153

Immunomodulation by adriamycin. Keywords Mesh Terms:

KEYWORDS: Neoplasms, Experimental

MESH TERMS: immunology

Chemical & Substance for Abstract: Immunomodulation by adriamycin. Information

Substance Name: Doxorubicin

Registry Number: 23214-92-8

Grant and Affiliation Information for Immunomodulation by adriamycin.

AFFILIATION:

Country: JAPAN

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Sci Rep Res Inst Tohoku Univ [

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Immunomodulation by adriamycin Related Publications

• Antitumor and toxicologic effects of p-carboxycarbanilic acid, N-(p-(bis(2-chloroethyl)amino)phenyl) ester (NSC-130998; IC 140).
• Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential.
• Design of adjuvant chemotherapy based on target cell determinants of drug action: possibilities and limitations.
• Immunomodulation by adriamycin.
• Selective imbalances of cellular immune responses by adriamycin.
• [Possibility of hyaluronidase and lysozyme rendering the lung permeable to substances to which it is normally impervious.]